Kenvue Inc. $KVUE Shares Acquired by NEOS Investment Management LLC

NEOS Investment Management LLC grew its stake in Kenvue Inc. (NYSE:KVUE) by 49.3% during the 3rd quarter, HoldingsChannel reports. The firm owned 241,756 shares of the company’s stock after buying an additional 79,835 shares during the quarter. NEOS Investment Management LLC’s holdings in Kenvue were worth $3,924,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in KVUE. Salomon & Ludwin LLC purchased a new position in Kenvue in the third quarter valued at $25,000. NBT Bank N A NY raised its holdings in Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after purchasing an additional 1,006 shares during the period. Cornerstone Planning Group LLC boosted its position in Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after purchasing an additional 1,361 shares in the last quarter. Golden State Wealth Management LLC grew its holdings in Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after purchasing an additional 1,190 shares during the period. Finally, Trust Co. of Vermont grew its holdings in Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after purchasing an additional 804 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

KVUE has been the topic of a number of research analyst reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Johnson Rice reiterated a “neutral” rating on shares of Kenvue in a research report on Tuesday, October 28th. Edward Jones cut shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Zacks Research upgraded shares of Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Finally, Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and decreased their target price for the company from $23.00 to $18.00 in a report on Friday, January 30th. Four analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $20.08.

Kenvue Price Performance

Shares of NYSE KVUE opened at $18.68 on Friday. The company has a market cap of $35.78 billion, a price-to-earnings ratio of 24.25 and a beta of 0.59. The stock’s 50-day moving average is $17.51 and its two-hundred day moving average is $17.67. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.86% and a net margin of 9.72%.The company had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $3.68 billion. During the same period last year, the firm earned $0.26 earnings per share. Kenvue’s quarterly revenue was up 3.2% on a year-over-year basis. Analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th will be paid a $0.2075 dividend. The ex-dividend date is Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.4%. Kenvue’s payout ratio is currently 110.67%.

Insider Activity at Kenvue

In related news, Director Jeffrey C. Smith purchased 3,200,000 shares of the stock in a transaction that occurred on Friday, December 12th. The shares were purchased at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the acquisition, the director directly owned 27,307,632 shares in the company, valued at $474,333,567.84. This represents a 13.27% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.68% of the company’s stock.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.